Literature DB >> 21233782

Epidemiology and risk factors for Clostridium difficile infection in children.

Thomas J Sandora1, Monica Fung, Kathleen Flaherty, Laura Helsing, Patricia Scanlon, Gail Potter-Bynoe, Courtney A Gidengil, Grace M Lee.   

Abstract

BACKGROUND: Pediatric Clostridium difficile infection (CDI)-related hospitalizations are increasing. We sought to describe the epidemiology of pediatric CDI at a quaternary care hospital.
METHODS: Nested case-control study within a cohort of children <18 years tested for C. difficile between January and August 2008. The study included patients who were ≥ 1 year with a positive test and diarrhea; those without diarrhea (ie, presumed colonization) were excluded. Two unmatched controls per case were randomly selected from patients ≥ 1 year with a negative test. Potential predictors of CDI included age, gender, comorbidities, prior hospitalization, receipt of C. difficile-active antibiotics in the prior 24 hours, and recent (≤ 4 weeks) exposure to antibiotics or acid-blocking medications. Multivariate logistic regression models were created to identify independent predictors of CDI.
RESULTS: Of 1891 tests performed, 263 (14%) were positive in 181 children. Ninety-five patients ≥ 1 year with CDI were compared with 238 controls. In multivariate analyses, predictors of CDI included solid organ transplant (odds ratio [OR], 8.09; 95% confidence interval [CI], 2.10-31.12), lack of prior hospitalization (OR, 8.43; 95% CI, 4.39-16.20), presence of gastrostomy or jejunostomy (G or J) tube (OR, 3.32; 95% CI 1.71-6.42), and receipt of fluoroquinolones (OR, 17.04; 95% CI, 5.86-49.54) or nonquinolone antibiotics (OR, 2.23; 95% CI, 1.18-4.20) in the past 4 weeks. Receipt of C. difficile-active antibiotics within 24 hours before testing was associated with a lower odds of CDI (OR, 0.22; 95% CI, 0.09-0.58).
CONCLUSIONS: Recent antibiotic exposure and certain comorbid conditions (solid organ transplant, presence of a gastrostomy or jejunostomy tube) were associated with CDI. Diagnostic testing has less utility in patients being treated with C. difficile-active antibiotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233782     DOI: 10.1097/INF.0b013e31820bfb29

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  46 in total

1.  A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.

Authors:  Jonathan D Crews; Hoonmo L Koo; Zhi-Dong Jiang; Jeffrey R Starke; Herbert L DuPont
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Effect of Metronidazole in Infants with Bowel Habit Change: Irrelative to the Clostridium difficile Colonization.

Authors:  Eun Jin Kim; Sung Hyun Lee; Hann Tchah; Eell Ryoo
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-03-27

3.  Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report.

Authors:  Joseph A Spinner; Claire E Bocchini; Ruth A Luna; Santosh Thapa; Miriam A Balderas; Susan W Denfield; William J Dreyer; Dorottya Nagy-Szakal; Faith D Ihekweazu; James Versalovic; Tor Savidge; Richard Kellermayer
Journal:  Pediatr Transplant       Date:  2019-10-16

Review 4.  An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.

Authors:  Jillian M Cotter; Maribeth R Nicholson; Larry K Kociolek
Journal:  J Pediatric Infect Dis Soc       Date:  2019-12-27       Impact factor: 3.164

5.  Narrowing of the Diagnostic Gap of Acute Gastroenteritis in Children 0-6 Years of Age Using a Combination of Classical and Molecular Techniques, Delivers Challenges in Syndromic Approach Diagnostics.

Authors:  Andrej Steyer; Monika Jevšnik; Miroslav Petrovec; Marko Pokorn; Štefan Grosek; Adela Fratnik Steyer; Barbara Šoba; Tina Uršič; Tjaša Cerar Kišek; Marko Kolenc; Marija Trkov; Petra Šparl; Raja Duraisamy; W Ian Lipkin; Sara Terzić; Mojca Kolnik; Tatjana Mrvič; Amit Kapoor; Franc Strle
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

Review 6.  Clostridium difficile: an emerging pathogen in children.

Authors:  Natalia Khalaf; Jonathan D Crews; Herbert L DuPont; Hoonmo L Koo
Journal:  Discov Med       Date:  2012-08       Impact factor: 2.970

7.  Community-acquired Clostridium difficile infection in Serbian pediatric population.

Authors:  Stojanović Predrag; Kocić Branislava; Stojanović Nikola; Radulovic Niko; Stojanović-Radić Zorica; Dobrila Stanković-Đorđević
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-03-01       Impact factor: 3.267

Review 8.  Co-infection as a confounder for the role of Clostridium difficile infection in children with diarrhoea: a summary of the literature.

Authors:  H de Graaf; S Pai; D A Burns; J A Karas; D A Enoch; S N Faust
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-01       Impact factor: 3.267

9.  Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.

Authors:  V Sathyendran; G N McAuliffe; T Swager; J T Freeman; S L Taylor; S A Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-09       Impact factor: 3.267

Review 10.  Clostridium difficile Infection in Children: Current State and Unanswered Questions.

Authors:  Pranita D Tamma; Thomas J Sandora
Journal:  J Pediatric Infect Dis Soc       Date:  2012-07-25       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.